BioUtah, Utah's trade association dedicated to the life sciences community, has announced that early bird registration is now open for the 2026 Utah Life Sciences Summit (ULSS). The summit, presented by Mayer Brown, will be held on November 11 at the Hilton Salt Lake City Center. Early bird discounts are available until October 11, providing an opportunity for participants to register at a reduced price.
The announcement carries significant implications for Utah's life sciences industry, which is a key driver of the state's economy and healthcare advancement. By offering discounted registration, BioUtah aims to ensure broad participation from professionals across the sector, fostering collaboration and innovation. The summit serves as a critical platform for stakeholders to discuss emerging trends, share knowledge, and address challenges facing the industry.
A highlight of the event is the keynote speaker, Dr. Michelle Tarver, Director of the FDA's Center for Devices and Radiological Health (CDRH). Dr. Tarver will host an in-person Town Hall discussion, providing attendees with a unique opportunity to engage directly with a top regulatory official. This interaction is particularly important as the life sciences sector navigates complex regulatory landscapes, and direct dialogue with the FDA can help companies better understand compliance and approval processes.
The summit will feature topic-specific tracks including workforce, regulatory, legal, and artificial intelligence. These tracks reflect the multifaceted nature of the life sciences industry and the need for specialized knowledge in these areas. The workforce track, for instance, addresses the talent pipeline and skills gap that many companies face, while the AI track explores the growing role of artificial intelligence in drug discovery, diagnostics, and patient care. The regulatory and legal tracks will provide updates on evolving policies and frameworks that impact the industry.
For those interested in attending, early bird registration is available now. To view the full announcement, including downloadable images, bios, and more, click here. BioUtah, an independent 501(c)(6) trade association, serves a broad spectrum of member companies with strengths in medical device manufacturing, research and testing, biotechnology, biopharmaceuticals, and diagnostics. The summit is expected to draw professionals from across these domains, facilitating networking and partnership opportunities.
The event's timing is crucial as the life sciences industry continues to evolve rapidly, driven by technological advancements and regulatory changes. By bringing together experts and decision-makers, the ULSS aims to catalyze progress and strengthen Utah's position as a hub for life sciences innovation. The early bird discount incentivizes early commitment, ensuring that a diverse range of participants can benefit from the summit's offerings.
In summary, the 2026 Utah Life Sciences Summit represents a vital convening for the industry, and the early bird registration period is now open. Stakeholders are encouraged to take advantage of the reduced rates before October 11. For more information about BioUtah, visit BioUtah.
